Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.320
+0.080 (6.45%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Cellectis Stock Forecast
CLLS's stock price has decreased by -51.13% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cellectis stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 430.30% from the current stock price of 1.32.
Analyst Consensus: Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for Cellectis stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +278.79% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +657.58% | Jun 12, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +354.55% | May 31, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +354.55% | Nov 1, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +733.33% | Aug 8, 2023 |
Financial Forecast
Revenue This Year
49.84M
from 49.22M
Increased by 1.26%
Revenue Next Year
25.75M
from 49.84M
Decreased by -48.33%
EPS This Year
-0.99
from -0.41
EPS Next Year
-0.61
from -0.99
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 99.9M | 26.3M | 88.5M | ||
| Avg | 49.8M | 25.8M | 86.8M | ||
| Low | 19.6M | 24.5M | 82.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 103.0% | -47.3% | 243.7% | ||
| Avg | 1.3% | -48.3% | 237.1% | ||
| Low | -60.2% | -50.8% | 220.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.80 | -0.30 |
| Avg | -0.99 | -0.61 |
| Low | -1.14 | -0.85 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.